Melatonin Treatment for Tardive Dyskinesia
Authors:
- Eyal ShamirESEyal Shamir
- Yoram BarakYBYoram Barak
- Irena ShalmanISIrena Shalman
- Moshe LaudonMLMoshe Laudon
- Nava ZisapelNZNava Zisapel
- Ricardo TarraschRTRicardo Tarrasch
- Avner ElizurAEAvner Elizur
- Ronit WeizmanRWRonit Weizman
- 1 November 2001
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 58 (11) , 1049-1052
Abstract
Research from JAMA Psychiatry — Melatonin Treatment for Tardive Dyskinesia — A Double-blind, Placebo-Controlled, Crossover StudyKeywords
This publication has 21 references indexed in Scilit:
- Vitamin E Treatment for Tardive DyskinesiaArchives of General Psychiatry, 1999
- Branched chain amino acids decrease tardive dyskinesia symptomsPsychopharmacology, 1999
- The Oxidant/Antioxidant Network: Role of MelatoninNeurosignals, 1999
- Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidolThe British Journal of Psychiatry, 1999
- Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic systemNeuroReport, 1998
- Progress in the Treatment of Tardive Dyskinesia: Theory and PracticePsychiatric Services, 1993
- Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjectsPsychiatry Research, 1990
- ALPHA-TOCOPHEROL IN TARDIVE DYSKINESIAThe Lancet, 1987
- Assessment of Tardive Dyskinesia Using the Abnormal Involuntary Movement ScaleJournal of Nervous & Mental Disease, 1985
- Inhibition of dopamine release by melatonin: regional distribution in the rat brainBrain Research, 1982